Work

The Efficacy and Safety of Zanghongqu Herbal Slices in the Treatment of Hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo controlled clinical trial

Year: 2026
Type: preprint
Study design: Study Protocol
Abstract: Introduction Dyslipidemia, especially the elevation of low-density lipoprotein cholesterol (LDL-C), is a significant risk factor for atherosclerotic cardiovascular disease (ASCVD). Although statins are recommended as a first-line treatment, their long-term application may be limited by adverse reactions and poor adherence in some patients. ZangHongQu(ZHQ) herbal slice is a novel red yeast rice formulation formed by the fermentation of highland barley and red yeast rice bacteria, containing natural Monacolin K and various bioactive components, which has lipid-lowering and metabolic regulatory effects. However, currently, there is a lack of high-quality randomized controlled trials systematically evaluating its efficacy and safety. This study aims to assess the efficacy and safety of ZHQ in treating dyslipidemia. Methods This study is a multicenter, randomized, double-blind, placebo-controlled clinical trial. It plans to enroll 240 patients aged 18–75 years with dyslipidemia and LDL-C ≥ 3.4 mmol/L. Participants will be randomly assigned in a 1:1 ratio to either the intervention group receiving ZHQ or the control group receiving placebo. The primary outcome measure is the change in LDL-C levels. Secondary outcomes include other lipid parameters, blood glucose, insulin, uric acid, and homocysteine levels. Safety assessments encompass liver and kidney function, creatine kinase, vital signs, and adverse events monitoring. Assessments will be conducted at baseline, 4 weeks, and 12 weeks after intervention. Discussion This study aims to provide high-quality evidence-based medicine for the efficacy and safety of ZHQ in treating dyslipidemia, and to provide a scientific basis for its potential application in cardiovascular risk management. Clinical Trial Registration and Ethics http://itmctr.ccebtcm.org.cn/ , ITMCTR2025001724. Ethical Review Number: 2025HL-359-01.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7161069083
Cites: 29
Cited by:
Related to: 10